Heska’s $175 Million Common Stock Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering.

Heska Corporation executed its $175 million public offering of 940,860 shares of common stock. The common stock is listed on the Nasdaq Global Select Market under the symbol “HSKA.”

Heska Corporation sells veterinary and animal health diagnostic and specialty products, including Point of Care diagnostic laboratory instruments and consumables, digital diagnostic imaging instruments, digital cytology services, vaccines, local and cloud-based data services, allergy testing and immunotherapy and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. Its core focus is on supporting veterinarians in the canine and feline healthcare space.

The Davis Polk corporate team advising J.P. Morgan Securities LLC and Piper Sandler & Co., as representatives of the several underwriters, included partner Alan F. Denenberg (Picture) and associate Dongbiao Shen. Counsel Kiara L. Rankin and associate Tomislava Dragicevic provided tax advice. Counsel Daniel F. Forester and associate S. Dream Montgomery provided intellectual property advice. 

Involved fees earner: Alan Denenberg – Davis Polk & Wardwell; Tomislava Dragicevic – Davis Polk & Wardwell; Daniel Forester – Davis Polk & Wardwell; S. Dream Montgomery – Davis Polk & Wardwell; Kiara Rankin – Davis Polk & Wardwell; Dongbiao Shen – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: J.P. Morgan Securities LLC; Piper Sandler;

Author: Martina Bellini